Overview

Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

Status:
Completed
Trial end date:
2020-03-19
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and safety of Ganovo combined with ritonavir for patients infected with SARS-CoV-2.
Phase:
Phase 4
Details
Lead Sponsor:
The Ninth Hospital of Nanchang
Collaborator:
Ascletis Pharmaceuticals Co., Ltd.
Treatments:
Interferons
Lopinavir
Peginterferon alfa-2a
Ritonavir